AstraZeneca Takes Drug-Pricing Law Challenge To 4th Circ.
AstraZeneca on Monday asked the Fourth Circuit to resurrect its suit challenging how the Centers for Medicare & Medicaid Services determines which drugs are subject to the landmark drug-pricing program, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article